Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human engineered monoclonal antibody specific for Transforming Growth Factor ß1

EU orphan designation number: EU/3/01/080
Active ingredient: Human engineered monoclonal antibody specific for Transforming Growth Factor ß1
Indication: Treatment of systemic sclerosis
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/02/2002 Orphan designation EMEA/OD/051/01 (2002)468 of 04/02/2002
10/11/2005 Removal of orphan designation from Community Register